Risk of colorectal cancer in first degree relatives of patients with colorectal polyps: nationwide case-control study in Sweden

Abstract Objective To assess the risk of colorectal cancer (CRC) in first degree relatives (parents and full siblings) of patients with precursor lesions (polyps) for CRC. Design Case-control study. Setting Linkage to the multi-generation register and gastrointestinal ESPRESSO (Epidemiology Strengthened by histoPathology Reports in Sweden) histopathology cohort in Sweden. Participants 68 060 patients with CRC and 333 753 matched controls. Main outcome measures Multivariable adjusted odds ratios of CRC according to the number of first degree relatives with a colorectal polyp and the histology of polyps and age at diagnosis in first degree relatives. Subgroup analysis was also performed according to age at CRC diagnosis and evaluated the joint association of family history of colorectal polyps and family history of CRC. Results After adjusting for family history of CRC and other covariates, having a first degree relative with a colorectal polyp (8.4% (5742/68 060) in cases and 5.7% (18 860/333 753) in controls) was associated with a higher risk of CRC (odds ratio 1.40, 95% confidence interval 1.35 to 1.45). The odds ratios ranged from 1.23 for those with hyperplastic polyps to 1.44 for those with tubulovillous adenomas. To better put this risk in perspective, the age specific absolute risk of colon and rectal cancers was estimated according to family history of polyps based on the 2018 national CRC incidence in Sweden. For example, the absolute risk of colon cancer in individuals aged 60-64 years with and without a family history of colorectal polyp was, respectively, 94.3 and 67.9 per 100 000 for men and 89.1 and 64.1 per 100 000 for women. The association between family history of polyps and CRC risk was strengthened by the increasing number of first degree relatives with polyps (≥2 first degree relatives: 1.70, 1.52 to 1.90, P<0.001 for trend) and decreasing age at polyp diagnosis (<50 years: 1.77, 1.57 to 1.99, P<0.001 for trend). A particularly strong association was found for early onset CRC diagnosed before age 50 years (≥2 first degree relatives: 3.34, 2.05 to 5.43, P=0.002 for heterogeneity by age of CRC diagnosis). In the joint analysis, the odds ratio of CRC for individuals with two or more first degree relatives with polyps but no CRC was 1.79 (1.52 to 2.10), with one first degree relative with CRC but no polyps was 1.70 (1.65 to 1.76), and with two or more first degree relatives with both polyps and CRC was 5.00 (3.77 to 6.63) (P<0.001 for interaction). Conclusions After adjusting for family history of CRC, the siblings and children of patients with colorectal polyps are still at higher risk of CRC, particularly early onset CRC. Early screening for CRC might be considered for first degree relatives of patients with polyps.

[1]  U. Ladabaum,et al.  Prevalence and Clinical Features of Sessile Serrated Polyps: A Systematic Review. , 2020, Gastroenterology.

[2]  A. Joshi,et al.  Risk of colorectal cancer incidence and mortality after polypectomy: a Swedish record-linkage study. , 2020, The lancet. Gastroenterology & hepatology.

[3]  J. Ludvigsson,et al.  Validation of serrated polyps (SPs) in Swedish pathology registers , 2019, BMC Gastroenterology.

[4]  U. Ladabaum,et al.  Cost-Effectiveness and National Effects of Initiating Colorectal Cancer Screening for Average-Risk Persons at Age 45 Years Instead of 50 Years. , 2019, Gastroenterology.

[5]  Felix C. H. Chan,et al.  Global Increasing Incidence of Young-Onset Colorectal Cancer Across 5 Continents: A Joinpoint Regression Analysis of 1,922,167 Cases , 2019, Cancer Epidemiology, Biomarkers & Prevention.

[6]  A. Braillon Screening for Colorectal Cancer at Earlier Ages: Putting the Cart before the Horse. , 2019, Gastroenterology.

[7]  M. Neovius,et al.  The longitudinal integrated database for health insurance and labour market studies (LISA) and its use in medical research , 2019, European Journal of Epidemiology.

[8]  U. Ladabaum,et al.  Opportunities and Challenges in Moving From Current Guidelines to Personalized Colorectal Cancer Screening. , 2019, Gastroenterology.

[9]  J. Ludvigsson,et al.  Cohort profile: ESPRESSO (Epidemiology Strengthened by histoPathology Reports in Sweden) , 2019, Clinical epidemiology.

[10]  I. Soerjomataram,et al.  Performance of colorectal cancer screening in the European Union Member States: data from the second European screening report , 2018, Gut.

[11]  U. Ladabaum,et al.  Potential Intended and Unintended Consequences of Recommending Initiation of Colorectal Cancer Screening at Age 45 Years. , 2018, Gastroenterology.

[12]  Charles J. Kahi,et al.  Lowering the Starting Age for Colorectal Cancer Screening to 45 Years: Who Will Come…and Should They? , 2018, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[13]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[14]  D. Corley,et al.  When Should Guidelines Change? A Clarion Call for Evidence Regarding the Benefits and Risks of Screening for Colorectal Cancer at Earlier Ages. , 2018, Gastroenterology.

[15]  M. Bretthauer,et al.  From Colorectal Cancer Screening Guidelines to Headlines: Beware! , 2018, Annals of Internal Medicine.

[16]  C. Flowers,et al.  Colorectal cancer screening for average‐risk adults: 2018 guideline update from the American Cancer Society , 2018, CA: a cancer journal for clinicians.

[17]  Y. Niv Changing pathological diagnosis from hyperplastic polyp to sessile serrated adenoma: systematic review and meta-analysis , 2017, European journal of gastroenterology & hepatology.

[18]  David Lieberman,et al.  Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer. , 2017, Gastroenterology.

[19]  A. Jemal,et al.  Colorectal cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.

[20]  J. Ludvigsson,et al.  Outcomes of Pregnancies for Women Undergoing Endoscopy While They Were Pregnant: A Nationwide Cohort Study. , 2017, Gastroenterology.

[21]  S. Ng,et al.  Risk of Colorectal Neoplasia in Individuals With Self-Reported Family History: A Prospective Colonoscopy Study from 16 Asia-Pacific Regions , 2016, The American Journal of Gastroenterology.

[22]  A. Zauber,et al.  Understanding the contribution of family history to colorectal cancer risk and its clinical implications: A state‐of‐the‐science review , 2016, Cancer.

[23]  Molin Wang,et al.  Statistical methods for studying disease subtype heterogeneity , 2016, Statistics in medicine.

[24]  Gun Peggy Knudsen,et al.  Ethical aspects of registry-based research in the Nordic countries , 2015, Clinical epidemiology.

[25]  Reiko Nishihara,et al.  Long-term colorectal-cancer incidence and mortality after lower endoscopy. , 2013, The New England journal of medicine.

[26]  Charles J. Kahi,et al.  Serrated Lesions of the Colorectum: Review and Recommendations From an Expert Panel , 2012, The American Journal of Gastroenterology.

[27]  A. Zauber,et al.  Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. , 2012, The New England journal of medicine.

[28]  R. Steele,et al.  Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002) , 2010, Gut.

[29]  J. Ludvigsson,et al.  The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research , 2009, European Journal of Epidemiology.

[30]  L. Holmberg,et al.  The completeness of the Swedish Cancer Register – a sample survey for year 1998 , 2009, Acta oncologica.

[31]  C. Bonaiti-Pellié,et al.  Colonoscopic screening of first-degree relatives of patients with large adenomas: increased risk of colorectal tumors. , 2007, Gastroenterology.

[32]  Deborah Schrag,et al.  How much can current interventions reduce colorectal cancer mortality in the U.S.? , 2006, Cancer.

[33]  H. Quan,et al.  Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative Data , 2005, Medical care.

[34]  Sander Greenland,et al.  Model-based estimation of relative risks and other epidemiologic measures in studies of common outcomes and in case-control studies. , 2004, American journal of epidemiology.

[35]  T. Byers,et al.  First-degree relatives of patients with advanced colorectal adenomas have an increased prevalence of colorectal cancer. , 2003, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[36]  H. Nakama,et al.  Family history of colorectal adenomatous polyps as a risk factor for colorectal cancer. , 2000, European journal of cancer.

[37]  M R Treat,et al.  Family History of Colorectal Adenomatous Polyps and Increased Risk for Colorectal Cancer , 1998, Annals of Internal Medicine.

[38]  Colorectal Cancer Screening in Average-Risk Adults , 2019, Annals of Internal Medicine.

[39]  N. Samadder,et al.  Risk of colorectal cancer and adenomas in the families of patients with adenomas: A population‐based study in Utah , 2014, Cancer.

[40]  A. Ekbom The Swedish Multi-generation Register. , 2011, Methods in molecular biology.

[41]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[42]  S Greenland,et al.  Multivariate estimation of exposure-specific incidence from case-control studies. , 1981, Journal of chronic diseases.